Application 761378

Type
BLA
Sponsor
FORMYCON AG

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761378Ahzantiveaflibercept-mrbb351(k) BiosimilarRx2026-08-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AHZANTIVEAFLIBERCEPT-MRBBINJECTABLE;INJECTION2MG(0.05ML OF 40MG/ML)NoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AHZANTIVEAFLIBERCEPT-MRBBValorum Biologics, LLC289e4b90-f741-c0f6-e063-6394a90a20682025-10-27Warnings, Adverse reactionsExact identifier
application number: BLA761378

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82033SUPPL 2025-04-28
81627ORIG 2025-03-18
78969ORIG 2024-07-02
78942ORIG 2024-07-01